Ośrodek Badań Klinicznych LabMed Agnieszka Karczmarczyk, Filip Karczmarczyk s.c.

The research at Ośrodek Badań Klinicznych LabMed Agnieszka Karczmarczyk, Filip Karczmarczyk s.c. focuses on cardiovascular diseases, with studies centered on atherosclerotic cardiovascular disease, heart failure, hyperlipidemia, and related high-risk conditions. These trials are designed to evaluate new treatment options and better understand how to reduce serious heart and blood vessel complications.

• Studies in atherosclerotic cardiovascular disease and obesity are assessing whether new therapies can lower the risk of major heart, stroke, and vascular events.
• Trials in heart failure are exploring treatment approaches for people with reduced ejection fraction, preserved or mildly reduced ejection fraction, and added risks such as obesity or kidney impairment.
• Research involving chronic kidney disease and hypertension is examining whether combined therapies can improve both kidney and cardiovascular outcomes.
• Lipid-focused studies are testing ways to improve control of LDL cholesterol and help prevent future cardiovascular events.

Overall, this site is contributing to clinical research aimed at improving prevention, treatment effectiveness, and long-term outcomes in people with cardiovascular disease and overlapping metabolic or kidney-related conditions.